Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Identification of optimized Aurora Kinase A PROTACs with suitable PK properties for in vivo proof-of-concept studies (OPTIMAPK).

Outputs and Outcomes

Promotor

Serge Van Calenbergh

Department of Pharmaceutics

Business Developer

Dominic De Groote

Department of Pharmaceutics (until 22 September 2024)

Platform Collaborator

Department of Pharmaceutics